ArticleJournal of the American Heart Association2024

Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level.

Yi-Wei Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.